Back to Treatments

Treatment

Bevacizumab + Pemetrexed + Cisplatin

1
Conditions
3
Trials
3,000
Participants
20%
Average Safety

Condition Evidence

Mesothelioma

3 trials · 3,000 participants

65% effectiveness · 20% safety
Bevacizumab + Pemetrexed + Cisplatin | DFDA